New horizons for cutaneous microbiology: The role of biofilms in dermatological disease

British Journal of Dermatology

Volumn 165, Issue 4, 2011, Pages 751-759

  Vlassova, N ^a   Han, A ^b   Zenilman, J M ^b   James, G ^c   Lazarus, G S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; AZITHROMYCIN; CARBAPENEM; CEFAMANDOLE; CEFTAZIDIME; DOXYCYCLINE; GAMMA BUTYROLACTONE; GENTAMICIN; IMIPENEM; INTERLEUKIN 12; LEVOFLOXACIN; N (3 OXODODECANOYL)HOMOSERINE LACTONE; N ACYLHOMOSERINE LACTONE; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; REACTIVE OXYGEN METABOLITE; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN; VIRULENCE FACTOR;

ACNE VULGARIS; ANAEROBE; ANTIBIOTIC RESISTANCE; APOPTOSIS; ATOPIC DERMATITIS; BACTERIAL CELL; BACTERIAL COLONIZATION; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL METABOLISM; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTEROIDES; BIOFILM; BURKHOLDERIA PSEUDOMALLEI; CANDIDA; CELL COMMUNICATION; CELL DENSITY; CELL MIGRATION; CELL PROLIFERATION; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; DERMATOPHYTE; DIABETES MELLITUS; ESCHERICHIA COLI; FIBROBLAST; FURUNCULOSIS; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENE TRANSFER; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HOST PATHOGEN INTERACTION; HUMAN; IMPETIGO; KERATINOCYTE; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MICROBIAL COMMUNITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUTRIENT AVAILABILITY; ONYCHOMYCOSIS; OXIDATIVE STRESS; PHENOTYPE; PLANKTON; PRIORITY JOURNAL; PROPIONIBACTERIUM; PROPIONIBACTERIUM ACNES; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; REVIEW; SESSILE SPECIES; SIGNAL TRANSDUCTION; SKIN DISEASE; SKIN EPITHELIUM; SKIN FLORA; SKIN INJURY; SPOROGENESIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS SANGUINIS; SWEAT GLAND DISEASE; TRANSMISSION ELECTRON MICROSCOPY; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM; VENOUS STASIS; WOUND HEALING;

ACNE VULGARIS; ANTI-BACTERIAL AGENTS; BIOFILMS; DERMATITIS, ATOPIC; FURUNCULOSIS; HUMANS; IMPETIGO; MICROBIAL SENSITIVITY TESTS; MILIARIA; ONYCHOMYCOSIS; SKIN; SKIN DISEASES, BACTERIAL;

EID: 80053463779     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10458.x     Document Type: Review

References (124)

1. Bisno AL,. Cutaneous infections: microbiologic and epidemiologic considerations. Am J Med 1984; 15: 172-9. (Pubitemid 14145884)
2. Grice EA, Kong HH, Renaud G, et al. A diversity profile of the human skin microbiota. Genome Res 2008; 18: 1043-50. (Pubitemid 351931155)
3. Landini P, Antoniani D, Burgess JG, Nijland R,. Molecular mechanisms of compounds affecting bacterial biofilm formation and dispersal. Appl Microbiol Biotechnol 2010; 86: 813-23.
4. Davis SC, Ricotti C, Cazzaniga A, et al. Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo. Wound Repair Regen 2008; 16: 23-9.
5. Burkhart CN, Burkhart CG,. Microbiology's principle of biofilms as a major factor in the pathogenesis of acne vulgaris. Int J Dermatol 2003; 42: 925-7. (Pubitemid 38004460)
6. Hoiby N, Bjarnsholt T, Givskov M, et al. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 2010; 35: 322-32.
7. Martin JM, Zenilman JM, Lazarus GS,. Molecular microbiology: new dimensions for cutaneous biology and wound healing. J Invest Dermatol 2010; 130: 38-48.
8. Donlan RM, Costerton JW,. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15: 167-93. (Pubitemid 34303762)
9. Sutherland IW,. The biofilm matrix-an immobilized but dynamic microbial environment. Trends Microbiol 2001; 9: 222-7. (Pubitemid 32402231)
10. Wolcott RD, Ehrlich GD,. Biofilms and chronic infections. JAMA 2008; 299: 2682-4. (Pubitemid 351831599)
11. Dunne WM,. Effects of subinhibitory concentrations of vancomycin or cefamandole on biofilm production by coagulase-negative staphylococci. Antimicrob Agents Chemother 1990; 34: 390-3.
12. Linares JF, Gustafsson I, Baquero F, Martinez JL,. Antibiotics as intermicrobial signaling agents instead of weapons. Proc Natl Acad Sci USA 2006; 103: 19484-9. (Pubitemid 46026057)
13. Starner TD, Shrout JD, Parsek MR, et al. Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and diminish established biofilms. Antimicrob Agents Chemother 2008; 52: 137-45.
14. Skindersoe ME, Alhede M, Phipps R, et al. Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2008; 52: 3648-63.
15. Periasamy S, Kolenbrander PE,. Mutualistic biofilm communities develop with Porphyromonas gingivalis and initial, early, and late colonizers of enamel. J Bacteriol 2009; 191: 6804-11.
16. Presterl E, Grisold AJ, Reichmann S, et al. Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics. J Antimicrob Chemother 2005; 55: 45-50. (Pubitemid 40192612)
17. Bjarnsholt T, Jensen PØ, Fiandaca MJ, et al. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulmonol 2009; 44: 547-58.
18. Hall-Stoodley L, Hu FZ, Gieseke A, et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 2006; 296: 202-11. (Pubitemid 44050374)
19. Sanderson AR, Leid JG, Hunsaker D,. Bacterial biofilms on the sinus mucosa of human subjects with chronic rhinosinusitis. Laryngoscope 2006; 116: 1121-6. (Pubitemid 44317935)
20. Mazzoli S,. Biofilms in chronic bacterial prostatitis (NIH-II) and in prostatic calcifications. FEMS Immunol Med Microbiol 2010; 59: 337-44.
21. Brady RA,. Osteomyelitis and the role of biofilms in chronic infection. FEMS Immunol Med Microbiol 2008; 52: 13-22.
22. Jones JW, Paull SN,. Effect of biofilm culture on antibiotic susceptibility of lactobacilli causing endocarditis. J Infect 1995; 31: 80-1.
23. Trampuz A, Zimmerli W,. Prosthetic joint infections: update in diagnosis and treatment. Swiss Med Wkly 2005; 135: 243-51. (Pubitemid 40769561)
24. Auler ME, Morreira D, Rodrigues FF, et al. Biofilm formation on intrauterine devices in patients with recurrent vulvovaginal candidiasis. Med Mycol 2010; 48: 211-16.
25. Zegans ME, Shanks RM, O'Toole GA,. Bacterial biofilms and ocular infections. Ocul Surf 2005; 3: 73-80. (Pubitemid 40775109)
26. Raad I, Chatzinikolaou I, Chaiban G, et al. In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrob Agents Chemother 2003; 47: 3580-5. (Pubitemid 37345723)
27. Werthen M, Henriksson L, Jensen PØ, et al. An in vitro model of bacterial infections in wounds and other soft tissues. APMIS 2010; 118: 156-64.
28. Mack D,. Molecular mechanisms of Staphylococcus epidermidis biofilm formation. J Hosp Infect 1999; 43 (Suppl.): S113-25.
29. Wright JA, Nair SP,. Interaction of staphylococci with bone. Int J Med Microbiol 2010; 300: 193-204.
30. von Eiff C, Peters G, Becker K,. The small colony variant (SCV) concept-the role of staphylococcal SCVs in persistent infections. Injury 2006; 37 (Suppl. 2): S26-33.
31. Kahl B, Herrmann M, Everding AS, et al. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis 1998; 177: 1023-9. (Pubitemid 28155157)
32. Costerton JW, Stewart PS, Greenberg EP,. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284: 1318-22. (Pubitemid 29289651)
33. Bjarnsholt T, Givskov M,. The role of quorum sensing in the pathogenicity of the cunning aggressor Pseudomonas aeruginosa. Anal Bioanal Chem 2007; 387: 409-14. (Pubitemid 46067458)
34. Decho AW, Norman RS, Visscher PT,. Quorum sensing in natural environments: emerging views from microbial mats. Trends Microbiol 2010; 18: 73-80.
35. Czajkowski R, Jafra S,. Quenching of acyl-homoserine lactone-dependent quorum sensing by enzymatic disruption of signal molecules. Acta Biochim Pol 2009; 56: 1-16.
36. Fuqua C, Greenberg EP,. Listening in on bacteria: acyl-homoserine lactone signalling. Nat Rev Mol Cell Biol 2002; 3: 685-95. (Pubitemid 34987789)
37. Waters CM, Bassler BL,. Quorum sensing: cell-to-cell communication in bacteria. Annu Rev Cell Dev Biol 2005; 21: 319-46. (Pubitemid 41740638)
38. Bassler BL, Losick R,. Bacterially speaking. Cell 2006; 125: 237-46.
39. Raina S, De Vizio D, Odell M, et al. Microbial quorum sensing: a tool or a target for antimicrobial therapy? Biotechnol Appl Biochem 2009; 54: 65-84.
40. Duan K, Dammel C, Stein J, et al. Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. Mol Microbiol 2003; 50: 1477-91. (Pubitemid 38010446)
41. Camilli A, Bassler BL,. Bacterial small-molecule signaling pathways. Science 2006; 311: 1113-16.
42. Kong KF, Vuong C, Otto M,. Staphylococcus quorum sensing in biofilm formation and infection. Int J Med Microbiol 2006; 296: 133-9. (Pubitemid 43375996)
43. Lõpez D, Vlamakis H, Kolter R,. Biofilms. Cold Spring Harb Perspect Biol 2010; 2:a00039.
44. Otto M,. Staphylococcal biofilms. Curr Top Microbiol Immunol 2008; 322: 207-28.
45. Neut D, van der Mei HC, Bulstra SK, Busscher HJ,. The role of small-colony variants in failure to diagnose and treat biofilm infections in orthopedics. Acta Orthop 2007; 78: 299-308. (Pubitemid 47027135)
46. O'Malley CA,. Infection control in cystic fibrosis: cohorting, cross-contamination, and the respiratory therapist. Respir Care 2009; 54: 641-57.
47. Smith RS, Fedyk ER, Springer TA, et al. IL-8 production in human lung fibroblasts and epithelial cells activated by the Pseudomonas autoinducer N-3-oxododecanoyl homoserine lactone is transcriptionally regulated by NF-kappa B and activator protein-2. J Immunol 2001; 167: 366-74. (Pubitemid 32567801)
48. DiMango E, Zar HJ, Bryan R, Prince A,. Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J Clin Invest 1995; 96: 2204-10.
49. Smith RS, Kelly R, Iglewski BH, Phipps RP,. The Pseudomonas autoinducer N-(3-oxododecanoyl) homoserine lactone induces cyclooxygenase-2 and prostaglandin E2 production in human lung fibroblasts: implications for inflammation. J Immunol 2002; 169: 2636-42. (Pubitemid 34921010)
50. Telford G, Wheeler D, Williams P, et al. The Pseudomonas aeruginosa quorum-sensing signal molecule N-(3-oxododecanoyl)-L-homoserine lactone has immunomodulatory activity. Infect Immun 1998; 66: 36-42.
51. Smith RS, Iglewski BH,. Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target. J Clin Invest 2003; 112: 1460-5. (Pubitemid 38056270)
52. Schaber JA,. Pseudomonas aeruginosa forms biofilms in acute infection independent of cell-to-cell signaling. Infect Immun 2007; 75: 3715-21. (Pubitemid 47206268)
53. Rumbaugh KP, Griswold JA, Iglewski BH, et al. Contribution of quorum sensing to the virulence of Pseudomonas aeruginosa in burn wound infections. Infect Immun 1999; 67: 5854-62. (Pubitemid 29508110)
54. Flemming HC, Neu TR, Wozniak DJ,. The EPS matrix: the 'house of biofilm cells'. J Bacteriol 2007; 189: 7945-7. (Pubitemid 350178903)
55. Stoodley P, Cargo R, Rupp CJ, et al. Biofilm material properties as related to shear-induced deformation and detachment phenomena. J Ind Microbiol Biotechnol 2002; 29: 361-7. (Pubitemid 36071889)
56. Nickel JC, Ruseska I, Wright J, et al. Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob Agents Chemother 1985; 27: 619-24. (Pubitemid 15097672)
57. Prosser BL, Taylor D, Dix BA, Cleeland R,. Method of evaluating effects of antibiotics on bacterial biofilm. Antimicrob Agents Chemother 1987; 31: 1502-6. (Pubitemid 17140801)
58. Mah TF, O'Toole GA,. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001; 9: 34-9.
59. Anderson GG, O'Toole GA,. Innate and induced resistance mechanisms of bacterial biofilms. Curr Top Microbiol Immunol 2008; 322: 85-105.
60. Werner E, Roe F, Bugnicourt A, et al. Stratified growth in Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 2004; 70: 6188-96. (Pubitemid 39471869)
61. Keren I, Kaldalu N, Spoering A, et al. Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett 2004; 230: 13-18. (Pubitemid 38091733)
62. Novick RP,. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 2003; 48: 1429-49. (Pubitemid 36751052)
63. Driffield K, Miller K, Bostock JM, et al. Increased mutability of Pseudomonas aeruginosa in biofilms. J Antimicrob Chemother 2008; 61: 1053-6. (Pubitemid 351524449)
64. Burne RA, Quivey RG Jr, Marquis RE,. Physiologic homeostasis and stress responses in oral biofilms. Methods Enzymol 1999; 310: 441-60. (Pubitemid 29504297)
65. Mandsberg LF, Ciofu O, Kirkby N, et al. Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system. Antimicrob Agents Chemother 2009; 53: 2483-91.
66. Molin S, Tolker-Nielsen T,. Gene transfer occurs with enhanced efficiency in biofilms and induces enhanced stabilisation of the biofilm structure. Curr Opin Biotechnol 2003; 14: 255-61. (Pubitemid 36782653)
67. Spencer DH, Kas A, Smith EE, et al. Whole-genome sequence variation among multiple isolates of Pseudomonas aeruginosa. J Bacteriol 2003; 185: 1316-25. (Pubitemid 36176864)
68. Battle SE, Rello J, Hauser AR,. Genomic islands of Pseudomonas aeruginosa. FEMS Microbiol Lett 2009; 290: 70-8.
69. Lewis K,. Persister cells and the riddle of biofilm survival. Biochemistry (Mosc) 2005; 70: 267-74. (Pubitemid 40512338)
70. Wagner VE, Li LL, Isabella VM, Iglewski BH,. Analysis of the hierarchy of quorum-sensing regulation in Pseudomonas aeruginosa. Anal Bioanal Chem 2007; 387: 469-79. (Pubitemid 46067462)
71. Wagner VE, Gillis RJ, Iglewski BH,. Transcriptome analysis of quorum-sensing regulation and virulence factor expression in Pseudomonas aeruginosa. Vaccine 2004; 22 (Suppl. 1): S15-20. (Pubitemid 39575366)
72. Karatan E, Watnick P,. Signals, regulatory networks, and materials that build and break bacterial biofilms. Microbiol Mol Biol Rev 2009; 73: 310-47.
73. Leid JG, Shirtliff ME, Costerton JW, Stoodley P,. Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect Immun 2002; 70: 6339-45. (Pubitemid 35192726)
74. Price LB, Liu CM, Melendez JH, et al. Community analysis of chronic wound bacteria using 16S rRNA gene-based pyrosequencing: impact of diabetes and antibiotics on chronic wound microbiota. PLoS ONE 2009; 4: e6462.
75. Dowd SE, Sun Y, Secor PR, et al. Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol 2008; 8: 43.
76. Malic S, Hill KE, Hayes A, et al. Detection and identification of specific bacteria in wound biofilms using peptide nucleic acid fluorescent in situ hybridization (PNA FISH). Microbiology 2009; 155: 2603-11.
77. Bjarnsholt T, Kirketerp-Møller K, Jensen PØ, et al. Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen 2008; 16: 2-10.
78. Kirker KR, Secor PR, James GA, et al. Loss of viability and induction of apoptosis in human keratinocytes exposed to Staphylococcus aureus biofilms in vitro. Wound Repair Regen 2009; 17: 690-9.
79. Kirketerp-Møller K, Jensen PØ, Fazli M, et al. Distribution, organization, and ecology of bacteria in chronic wounds. J Clin Microbiol 2008; 46: 2717-22.
80. James GA, Swogger E, Wolcott R, et al. Biofilms in chronic wounds. Wound Repair Regen 2008; 16: 37-44.
81. Cunningham AB, Lennox JE, Ross RJ, eds. Biofilms: The Hypertextbook. Bozeman, MT: Center for Biofilm Engineering, Montana State University. 2011. Available at: (last accessed 21 June 2011).
82. Stoodley P, Debeer D, Longwell M, et al. Tonsillolith: not just a stone but a living biofilm. Otolaryngol Head Neck Surg 2009; 141: 316-21.
83. Lai Y, Di Nardo A, Nakatsuji T, et al. Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat Med 2009; 15: 1377-82.
84. Lai Y, Cogen AL, Radek KA, et al. Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections. J Invest Dermatol 2010; 130: 2211-21.
85. Drenkard E, Ausubel FM,. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 2002; 416: 740-3. (Pubitemid 34429150)
86. Reinhardt A, Köhler T, Wood P, et al. Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients. Antimicrob Agents Chemother 2007; 51: 1341-50. (Pubitemid 46586815)
87. Favre-Bonté S, Chamot E, Köhler T, et al. Autoinducer production and quorum-sensing dependent phenotypes of Pseudomonas aeruginosa vary according to isolation site during colonization of intubated patients. BMC Microbiol 2007; 7: 33.
88. Lewis K,. Multidrug tolerance of biofilms and persister cells. Curr Top Microbiol Immunol 2008; 322: 107-31.
89. Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003; 290: 2588-98. (Pubitemid 37443289)
90. Gao Z, Tseng CH, Strober BE, et al. Substantial alterations of the cutaneous bacterial biota in psoriatic lesions. PLoS ONE 2008; 3: e2719.
91. Draelos ZD,. Treating beyond the histology of rosacea. Cutis 2004; 3 (Suppl.): 28-34.
92. Brüggemann H, Henne A, Hoster F, et al. The complete genome sequence of Propionibacterium acnes, a commensal of human skin. Science 2004; 305: 671-3. (Pubitemid 39006756)
93. Burkhart CG, Burkhart CN,. Expanding the microcomedone theory and acne therapeutics: Propionibacterium acnes biofilm produces biological glue that holds corneocytes together to form plug. J Am Acad Dermatol 2007; 57: 722-4. (Pubitemid 47384925)
94. Burkhart CN, Burkhart CG,. Antibiotic-resistant Propionibacterium acnes may not be the major issue clinically or microbiologically in acne. Br J Dermatol 2003; 148: 365-6. (Pubitemid 36278988)
95. Coenye T, Peeters E, Nelis HJ,. Biofilm formation by Propionibacterium acnes is associated with increased resistance to antimicrobial agents and increased production of putative virulence factors. Res Microbiol 2007; 158: 386-92. (Pubitemid 46824036)
96. Qi X, Gao J, Sun D, et al. Biofilm formation of the pathogens of fatal bacterial granuloma after trauma: potential mechanism underlying the failure of traditional antibiotic treatments. Scand J Infect Dis 2008; 40: 221-8. (Pubitemid 351260430)
97. Holmberg A, Lood R, Mörgelin M, et al. Biofilm formation by Propionibacterium acnes is a characteristic of invasive isolates. Clin Microbiol Infect 2009; 15: 787-95.
98. Coenye T, Honraet K, Rossel B, et al. Biofilms in skin infections: Propionibacterium acnes and acne vulgaris. Infect Disord Drug Targets 2008; 8: 156-9.
99. James KA, Burkhart CN, Morrell DS,. Emerging drugs for acne. Expert Opin Emerg Drugs 2009; 14: 649-59.
100. Mowad CM, McGinley KJ, Foglia A, et al. The role of extracellular polysaccharide substance produced by Staphylococcus epidermidis in miliaria. J Am Acad Dermatol 1995; 33: 729-33.
101. Leung DYM, Eichenfield LF, Boguniewicz M,. Atopic dermatitis (atopic eczema). In: Fitzpatrick's Dermatology in General Medicine (, Wolff K, Goldsmith LA, Katz SI, Gilchrest BJ, Paller A, Leffell DJ, eds), 7th edn. 2008. New York: McGraw Hill, Chapter 14, online version.
102. Capoluongo E, Giglio AA, Lavieri MM, et al. Genotypic and phenotypic characterization of Staphylococcus aureus strains isolated in subjects with atopic dermatitis. Higher prevalence of exfoliative B toxin production in lesional strains and correlation between the markers of disease intensity and colonization density. J Dermatol Sci 2001; 26: 145-55. (Pubitemid 32510723)
103. Williams RE, Gibson AG, Aitchison TC, et al. Assessment of a contact-plate sampling technique and subsequent quantitative bacterial studies in atopic dermatitis. Br J Dermatol 1990; 123: 493-501. (Pubitemid 20344790)
104. Ogawa T, Katsuoka K, Kawano K, Nishiyama S,. Comparative study of staphylococcal flora on the skin surface of atopic dermatitis patients and healthy subjects. J Dermatol 1994; 21: 453-60. (Pubitemid 24244326)
105. Akiyama H, Tada J, Toi J, et al. Changes in Staphylococcus aureus density and lesion severity after topical application of povidone-iodine in cases of atopic dermatitis. J Dermatol Sci 1997; 16: 23-30. (Pubitemid 28004770)
106. Akiyama H, Oono T, Huh WK, et al. Actions of gluco-oligosaccharide against Staphylococcus aureus. J Dermatol 2002; 29: 580-6.
107. Akiyama H, Hamada T, Huh WK, et al. Confocal laser scanning microscopic observation of glycocalyx production by Staphylococcus aureus in skin lesions of bullous impetigo, atopic dermatitis and pemphigus foliaceus. Br J Dermatol 2003; 148: 526-32. (Pubitemid 36461332)
108. Katsuyama M, Ichikawa H, Ogawa S, Ikezawa Z,. A novel method to control the balance of skin microflora. Part 1. Attack on biofilm of Staphylococcus aureus without antibiotics. J Dermatol Sci 2005; 38: 197-205.
109. Sommer S, Sheehan-Dare RA, Goodfield MJ, Evans EG,. Prediction of outcome in the treatment of onychomycosis. Clin Exp Dermatol 2003; 28: 425-8. (Pubitemid 36801850)
110. Trofa D, Gácser A, Nosanchuk JD,. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev 2008; 21: 606-25.
111. Sigurgeirsson B,. Prognostic factors for cure following treatment of onychomycosis. J Eur Acad Dermatol Venereol 2010; 24: 679-84.
112. Burkhart CN, Burkhart CG, Gupta AK,. Dermatophytoma: recalcitrance to treatment because of existence of fungal biofilm. J Am Acad Dermatol 2002; 47: 629-31.
113. Reynolds TB, Fink GR,. Bakers' yeast, a model for fungal biofilm formation. Science 2001; 291: 878-81. (Pubitemid 32120759)
114. Oliveira MT, Specian AF, Andrade CG, et al. Interaction of Candida parapsilosis isolates with human hair and nail surfaces revealed by scanning electron microscopy analysis. Micron 2010; 41: 604-8.
115. Arrese JE, Piérard-Franchimont C, Piérard GE,. Facing up to the diagnostic uncertainty and management of onychomycoses. Int J Dermatol 1999; 38 (Suppl. 2): 1-6. (Pubitemid 29469839)
116. Craft N, Lee PK, Zipoli MT, et al. Superficial cutaneous infections and pyodermas. In: Fitzpatrick's Dermatology in General Medicine (, Wolff K, Goldsmith LA, Katz SI, Gilchrest BJ, Paller A, Leffell DJ, eds), 7th edn. 2008. New York: McGraw Hill, Chapter 177, online version.
117. Akiyama H, Ueda M, Kanzaki H, et al. Biofilm formation of Staphylococcus aureus strains isolated from impetigo and furuncle: role of fibrinogen and fibrin. J Dermatol Sci 1997; 16: 2-10. (Pubitemid 28004767)
118. Yamasaki O, Akiyama H, Toi Y, Arata J,. A combination of roxithromycin and imipenem as an antimicrobial strategy against biofilms formed by Staphylococcus aureus. J Antimicrob Chemother 2001; 48: 573-7. (Pubitemid 33040703)
119. Akiyama H, Huh WK, Yamasaki O, et al. Confocal laser scanning microscopic observation of glycocalyx production by Staphylococcus aureus in mouse skin: does S. aureus generally produce a biofilm on damaged skin? Br J Dermatol 2002; 147: 879-85. (Pubitemid 35365433)
120. Akiyama H, Morizane S, Yamasaki O, et al. Assessment of Streptococcus pyogenes microcolony formation in infected skin by confocal laser scanning microscopy. J Dermatol Sci 2003; 32: 193-9. (Pubitemid 37162694)
121. Williams I, Venable WA, Lloyd D, et al. The effects of adherence to silicone surfaces on antibiotic susceptibility in Staphylococcus aureus. Microbiology 1997; 143: 2407-13. (Pubitemid 27356775)
122. Ceri H, Olson ME, Stremick C, et al. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999; 37: 771-6.
123. Vorachit M, Lam K, Jayanetra P, Costerton JW,. Resistance of Pseudomonas pseudomallei growing as a biofilm on silastic disks to ceftazidime and cotrimoxazole. Antimicrob Agents Chemother 1993; 37: 2000-2. (Pubitemid 23265569)
124. Larsen T, Fiehn NE,. Resistance of Streptococcus sanguis biofilms to antimicrobial agents. APMIS 1996; 104: 280-4. (Pubitemid 26166292)